Assessing Early Efficacy After Initiation of Once-Nightly Sodium Oxybate (ON-SXB; FT218) in Participants with Narcolepsy Type 1 or 2: A Post Hoc Analysis from the Phase 3 REST-ON TrialOnce-Nightly Sodium Oxybate Early EfficacyL. Krahn et al.

被引:1
|
作者
Lois Krahn [1 ]
Asim Roy [2 ]
John W. Winkelman [3 ]
Anne Marie Morse [4 ]
Jennifer Gudeman [5 ]
机构
[1] Mayo Clinic,Geisinger Commonwealth School of Medicine, Geisinger Medical Center
[2] Ohio Sleep Medicine Institute,Medical and Clinical Affairs
[3] Massachusetts General Hospital,undefined
[4] Janet Weis Children’s Hospital,undefined
[5] Avadel Pharmaceuticals,undefined
关键词
D O I
10.1007/s40263-024-01143-7
中图分类号
学科分类号
摘要
引用
收藏
页码:53 / 59
页数:6
相关论文
共 35 条
  • [1] EARLY EFFICACY WITH ONCE-NIGHTLY SODIUM OXYBATE (ON-SXB; FT218): POST-HOC ANALYSES FROM REST-ON
    Krahn, Lois
    Roy, Asim
    Winkelman, John
    Morse, Ann Marie
    Seiden, David
    Dubow, Jordan
    Gudeman, Jennifer
    SLEEP, 2022, 45 : A182 - A182
  • [2] EARLY EFFICACY WITH ONCE-NIGHTLY SODIUM OXYBATE (ON-SXB; FT218): POST-HOC ANALYSES FROM REST-ON
    Krahn, L.
    Roy, A.
    Winkelman, J.
    Morse, A. M.
    Seiden, D.
    Dubow, J.
    Gudeman, J.
    SLEEP MEDICINE, 2022, 100 : S155 - S156
  • [3] Efficacy of FT218, a Once-Nightly Sodium Oxybate Formulation (ON-SXB), by Narcolepsy Subtype: Post Hoc Analysis from REST-ON
    Roy, Asim
    Morse, Anne Marie
    Dubow, Jordan
    Seiden, David
    Bogan, Richard
    ANNALS OF NEUROLOGY, 2021, 90 : S239 - S239
  • [4] Efficacy of Once-Nightly Sodium Oxybate (ON-SXB; FT218) by Narcolepsy Type: Post-Hoc Analyses from the REST-ON Trial
    Dauvilliers, Yves
    Roth, Thomas
    Bogan, Richard
    Thorpy, Michael J.
    Morse, Anne Marie
    Roy, Asim
    Seiden, David
    Dubow, Jordan
    Gudeman, Jennifer
    ANNALS OF NEUROLOGY, 2022, 92 : S222 - S222
  • [5] EFFICACY OF ONCE-NIGHTLY SODIUM OXYBATE (ON-SXB; FT218) BY NARCOLEPSY TYPE: POST-HOC ANALYSES FROM THE REST-ON TRIAL
    Dauvilliers, Yves
    Roth, Thomas
    Bogan, Richard
    Thorpy, Michael
    Morse, Anne Marie
    Roy, Asim
    Seiden, David
    Dubow, Jordan
    Gudeman, Jennifer
    SLEEP, 2022, 45 : A179 - A180
  • [6] EFFICACY OF ONCE-NIGHTLY SODIUM OXYBATE (ON-SXB; FT218) BY NARCOLEPSY TYPE: POST-HOC ANALYSES FROM THE REST-ON TRIAL
    Dauvilliers, Y.
    Roth, T.
    Bogan, R.
    Thorpy, M.
    Morse, A. M.
    Roy, A.
    Seiden, D.
    Dubow, J.
    Gudeman, J.
    SLEEP MEDICINE, 2022, 100 : S157 - S157
  • [7] Weight Loss with FT218, a Once-Nightly Sodium Oxybate Formulation (ON-SXB), for the Treatment of Narcolepsy: Post Hoc Analysis from REST-ON
    Morse, Anne Marie
    Roy, Asim
    Dubow, Jordan
    Seiden, David
    Bogan, Richard
    ANNALS OF NEUROLOGY, 2021, 90 : S242 - S242
  • [8] Efficacy of FT218, a Once-Nightly Sodium Oxybate Formulation (ON-SXB), by Stimulant Use: Post Hoc Analysis from REST-ON
    Roy, Asim
    Morse, Anne Marie
    Dubow, Jordan
    Seiden, David
    Bogan, Richard
    ANNALS OF NEUROLOGY, 2021, 90 : S241 - S242
  • [9] Efficacy of once-nightly sodium oxybate (FT218) in narcolepsy type 1 and type 2: post hoc analysis from the Phase 3 REST-ON Trial
    Dauvilliers, Yves
    Roth, Thomas
    Bogan, Richard
    Thorpy, Michael J.
    Morse, Anne Marie
    Roy, Asim
    Dubow, Jordan
    Gudeman, Jennifer
    SLEEP, 2023, 46 (11)
  • [10] EFFICACY OF FT218, A ONCE-NIGHTLY SODIUM OXYBATE FORMULATION, BY NARCOLEPSY SUBTYPE: A POST HOC ANALYSIS FROM THE REST-ON STUDY
    Roy, Asim
    Morse, Anne Marie
    Dubow, Jordan
    Seiden, David
    Bogan, Richard
    SLEEP, 2021, 44 : A194 - A194